Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative esketamine infusion for recovery after arthroscopic rotator cuff repair
ChiCTR2400080589Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in rotator cuff tear (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Quality of recovery on postoperative day 1. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on ChiCTR2400080589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080589.